Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish ...

But Grifols's board and Brookfield said they weren't in takeover talks. "Brookfield is not, and has not been, in discussions with the company's board of directors with respect to a potential ...

MADRID (Reuters) -Shares in Spanish pharmaceutical company Grifols (BME:GRLS) rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from ...

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols (NASDAQ:GRFS), El Confidencial reported on Wednesday, citing ...

Grifols shares were up 4.4% at 8.49 euros ($9.18) after gaining 12% earlier in the day. The blue-chip IBEX35 index was down 0.1%. In its stock market filing, Brookfield said it maintained "a ...

Grifols' board also said on Wednesday it was not discussing a possible bid by Brookfield. The Grifols family, which is represented on the board, declined to comment. ($1 = 0.9246 euros) ...

A non-binding offer that valued Grifols at €6.45-billion ($10.02-billion) was withdrawn by Brookfield in November after Grifols management rejected it as too low and recommended shareholders ...

Get the latest Grifols, S.A. (GIFOF) stock news and headlines to help you in your trading and investment decisions.

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This decision follows the company’s November 19 ...

Grifols rejected Brookfield's $6.81 billion acquisition bid, citing undervaluation of growth potential and long-term prospects. Revenue grew 9.1% YoY in the first nine months of 2024, with ...